Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Lynn Estes, Robert Orenstein

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalClinical Therapeutics
Volume29
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Linezolid
Drug Dose Response Relationship
Acetamides
Staphylococcal Pneumonia
Oxazolidinones
Methicillin Resistance
Decision Support Techniques
Vancomycin
Methicillin-Resistant Staphylococcus aureus
Cross Infection
Cost-Benefit Analysis
Staphylococcus aureus
Pneumonia
Research Design
Randomized Controlled Trials
Retrospective Studies
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{dee33f849318413bbb0ddefc55c923a0,
title = "Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.",
author = "Lynn Estes and Robert Orenstein",
year = "2007",
month = "2",
doi = "10.1016/j.clinthera.2007.02.010",
language = "English (US)",
volume = "29",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "2",

}

TY - JOUR

T1 - Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

AU - Estes, Lynn

AU - Orenstein, Robert

PY - 2007/2

Y1 - 2007/2

UR - http://www.scopus.com/inward/record.url?scp=34547618072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547618072&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2007.02.010

DO - 10.1016/j.clinthera.2007.02.010

M3 - Article

C2 - 17472831

VL - 29

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 2

ER -